Jonathan Yen-Wen Yu - Dec 29, 2022 Form 3 Insider Report for Disc Medicine, Inc. (IRON)

Role
Chief Business Officer
Signature
/s/ Rahul Khara, attorney-in-fact
Stock symbol
IRON
Transactions as of
Dec 29, 2022
Transactions value $
$0
Form type
3
Date filed
1/3/2023, 04:05 PM
Next filing
Mar 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IRON Stock Option (Right to Buy) Dec 29, 2022 Common Stock 37.9K $2.65 Direct F1
holding IRON Stock Option (Right to Buy) Dec 29, 2022 Common Stock 16.4K $2.56 Direct F2
holding IRON Stock Option (Right to Buy) Dec 29, 2022 Common Stock 7.01K $9.86 Direct F3
holding IRON Stock Option (Right to Buy) Dec 29, 2022 Common Stock 45.3K $9.86 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vested on July 1, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2 2,730 shares underlying this option vested on July 1, 2021, with the remaining shares vesting in 40 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3 The shares underlying this option vest in 48 equal monthly installments following July 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
F4 The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney